The main asset and liability categories for discontinued operations on December 31, 2012 are the following: 31/12/2012 (eur 000)
Bioassays
Other
TOTAL
ASSETS Other intangible assets Property, plant and equipment Investments accounted for using the equity method Deferred tax assets Other long-term assets Non-current assets
40 2 808 13 145
6 2 697
4 240 6 057 2 691 40 2 814 15 842
Inventories and contracts in progress Trade receivables Other receivables Cash and cash equivalents Current assets
6 378 7 308 2 173 3 206 19 065
55 200 104 33 392
6 433 7 508 2 277 3 239 19 457
TOTAL ASSETS HELD FOR SALE
32 210
3 089
35 299
LIABILITIES Long-term provisions Other long-term liabilities Non-current liabilities
3 711 400 4 111
237
3 948 400 4 348
Trade payables Tax liabilities Other liabilities Current liabilities
1 839 -288 5 178 6 729
4 389 393
1 843 -288 5 567 7 122
TOTAL LIABILITIES DIRECTLY RELATED TO ASSETS HELD FOR SALE
10 840
630
11 470
NET ASSETS DIRECTLY RELATED TO OPERATIONS HELD FOR SALE
21 370
2 459
23 829
4 240 6 057 2 691
237
Included in the overall statement of comprehensive income for the financial year ending December 31, 2011 and December 31, 2012:
Actuarial reserves Revaluation reserves Currency translation differences Reserves for assets held for sale
December 31, 2011 (EUR 000)
December 31, 2012 (EUR 000)
-358 -835 1 717 524
-708 0 76 -632
December 31, 2011 (EUR 000)
December 31, 2012 (EUR 000)
4 602 -28 558 -4 299 -28 255
2 767 74 186 279 77 232
The net cash flows of the discontinued operations are the following:
Cash flow from operating activities Cash flow from investing activities Cash flow from financing activities Net change in cash flow from discontinued operations
Annual report 2012 // 103